XML 28 R15.htm IDEA: XBRL DOCUMENT v3.25.1
Note 7 - Common Stock
 12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Equity [Text Block]

Note 7 — Common Stock

 

The Company has 50,000,000 authorized shares of $0.001 par value common stock under its Amended and Restated Certificate of Incorporation.

 

For the years ended December 31, 2024, 2023 and 2022, the Company issued 266,353, 207,626 (net shares issued after a portion of 407,808 shares was a cashless exercise) and 25,000, respectively, of its common stock resulting from stock option exercises under its 2018 Equity Incentive Plan (see Note 9). The Company withheld 50,867 shares for payroll tax obligations totaling $180 for the year ended December 31, 2023. For the years ended December 31, 2024, 2023 and 2022, the Company issued 80,933, 86,782 shares and 69,884, respectively, under the Company’s Employee Stock Purchase Plan (“ESPP”). For the years ended December 31, 2024, 2023 and 2022, the Company issued 90,402, 91,402 and 0, respectively, in shares of its common stock due to the vesting of restricted stock units. 

 

On December 10, 2024, the Company entered into a securities purchase agreement with an institutional investor, pursuant to which the Company issued 583,334 shares of its common stock at an offering price of $12.00 per common share for gross proceeds to the Company of $7,000 before deducting any related offering expenses.